Granulocyte-colony stimulating factor improves MDX mouse response to peripheral nerve injury

PLoS One. 2012;7(8):e42803. doi: 10.1371/journal.pone.0042803. Epub 2012 Aug 13.

Abstract

Background: G-CSF has been shown to increase neuronal survival, which may positively influence the spinal cord microenvironment during the course of muscular dystrophies.

Methodology/principal findings: Male MDX mice that were six weeks of age received a left sciatic nerve transection and were treated with intraperitoneal injections of 200 µg/kg/day of G-CSF 7 days before and 7 days after the transection. The axotomy was performed after the cycles of muscular degeneration/regeneration, consistent with previous descriptions of this model of muscular dystrophy. C57BL/10 mice were used as control subjects. Seven days after the surgery, the animals were sacrificed and their lumbar spinal cords were processed for immunohistochemistry (anti-MHC I, anti-Synaptophysin, anti-GFAP and anti-IBA-1) and transmission electron microscopy. MHC I expression increased in both strains of mice after the axotomy. Nevertheless, the MDX mice displayed a significantly smaller MHC I upregulation than the control mice. Regarding GFAP expression, the MDX mice showed a stronger astrogliosis compared with the C57BL/10 mice across all groups. Both groups that were treated with G-CSF demonstrated preservation of synaptophysin expression compared with the untreated and placebo groups. The quantitative analysis of the ultrastructural level showed a preservation of the synaptic covering for the both groups that were treated with G-CSF and the axotomized groups showed a smaller loss of synaptic contact in relation to the treated groups after the lesion.

Conclusions/significance: The reduction of active inputs to the alpha-motoneurons and increased astrogliosis in the axotomized and control groups may be associated with the cycles of muscle degeneration/regeneration that occur postnatally. The G-CSF treated group showed a preservation of the spinal cord microenvironment after the lesion. Moreover, the increase of MHC I expression in the MDX mice that were treated with G-CSF may indicate that this drug performs an active role in regenerative potential after lesions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Axotomy / adverse effects
  • Biomarkers / metabolism
  • Calcium-Binding Proteins / metabolism
  • Gene Expression Regulation / drug effects
  • Granulocyte Colony-Stimulating Factor / pharmacology*
  • Granulocyte Colony-Stimulating Factor / therapeutic use
  • Histocompatibility Antigens / metabolism
  • Male
  • Mice
  • Mice, Inbred mdx
  • Microfilament Proteins / metabolism
  • Neuroglia / drug effects
  • Neuroglia / metabolism
  • Neuroglia / pathology
  • Neuroglia / ultrastructure
  • Neurons / diagnostic imaging
  • Neurons / drug effects
  • Neurons / metabolism
  • Neurons / pathology
  • Neuroprotective Agents / pharmacology*
  • Neuroprotective Agents / therapeutic use
  • Peripheral Nerve Injuries / drug therapy*
  • Peripheral Nerve Injuries / etiology
  • Peripheral Nerve Injuries / metabolism
  • Peripheral Nerve Injuries / pathology
  • Sciatic Nerve / injuries
  • Spinal Cord / drug effects
  • Spinal Cord / pathology
  • Spinal Cord / ultrastructure
  • Synapses / drug effects
  • Synapses / metabolism
  • Ultrasonography

Substances

  • Aif1 protein, mouse
  • Biomarkers
  • Calcium-Binding Proteins
  • Histocompatibility Antigens
  • Microfilament Proteins
  • Neuroprotective Agents
  • Granulocyte Colony-Stimulating Factor

Grants and funding

This work was funded by grants from Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnológico (CNPq) and Fundação de Amparo a Pesquisa do Estado de São Paulo (FAPESP - 2009/06686-6, 2009/05565-0 and 2012/14236-3). ALRO receives a fellowship from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.